<DOC>
	<DOCNO>NCT00256633</DOCNO>
	<brief_summary>TITLE : CSP 465-C , Fatty Acid Binding protein 2 ( FABP2 ) ancillary proposal CSP # 465 Glycemic Control Complications Diabetes Mellitus Type 2 . Angeliki Georgopoulos , M.D . Carlos Abraira M.D . William Duckworth M.D . Fatty acid bind protein 2 ( FABP2 ) involve transport long chain fatty acid across intestinal epithelium . A common ( 40-45 % ) polymorphism FABP2 gene ( codon 54 Threonine Alanine ) result increase intestinal fatty acid absorption triglyceride secretion ( Baier et al J Clin Invest 95:1281-87 , 1995 ; Baier et al J Biol Chem 271 : 10892-10896,1996 ) . We find ( JCEM 85:3155-60 , 2000 ) patient type 2 diabetes , codon 54 polymorphism FABP2 result fast postprandial hypertriglyceridemia . Since hypertriglyceridemia risk factor atherosclerosis type 2 diabetes part insulin resistance syndrome , objective ancillary study would screen participant CSP # 465 study polymorphism ass ) whether carry polymorphism respond differently various treatment modality b ) whether develop cardiovascular event compare one lack polymorphism . There one study suggest association polymorphism history parental stroke ( JCEM 85:2801-4 , 2000 ) . The additional request study participant agree collection blood sample use DNA isolation screen polymorphism . No additional fund request . If polymorphism prove predictor either response specific treatment modality risk macro-vascular complication , easy screen target treatment modality appropriately .</brief_summary>
	<brief_title>Fatty Acid Binding Protein 2 ( FABP2 ) Ancillary Proposal</brief_title>
	<detailed_description>Primary Hypothesis : Secondary Hypotheses : Primary Outcomes : Major cardiovascular event Study Abstract : TITLE : CSP 465-C , Fatty Acid Binding protein 2 ( FABP2 ) ancillary proposal CSP # 465 Glycemic Control Complications Diabetes Mellitus Type 2 . Angeliki Georgopoulos , M.D . Carlos Abraira M.D . William Duckworth M.D . Fatty acid bind protein 2 ( FABP2 ) involve transport long chain fatty acid across intestinal epithelium . A common ( 40-45 % ) polymorphism FABP2 gene ( codon 54 Threonine Alanine ) result increase intestinal fatty acid absorption triglyceride secretion ( Baier et al J Clin Invest 95:1281-87 , 1995 ; Baier et al J Biol Chem 271 : 10892-10896,1996 ) . We find ( JCEM 85:3155-60 , 2000 ) patient type 2 diabetes , codon 54 polymorphism FABP2 result fast postprandial hypertriglyceridemia . Since hypertriglyceridemia risk factor atherosclerosis type 2 diabetes part insulin resistance syndrome , objective ancillary study would screen participant CSP # 465 study polymorphism ass ) whether carry polymorphism respond differently various treatment modality b ) whether develop cardiovascular event compare one lack polymorphism . There one study suggest association polymorphism history parental stroke ( JCEM 85:2801-4 , 2000 ) . The additional request study participant agree collection blood sample use DNA isolation screen polymorphism . No additional fund request . If polymorphism prove predictor either response specific treatment modality risk macro-vascular complication , easy screen target treatment modality appropriately . The data analyze therefore result record/study .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients type 2 DM longer responsive maximum dose one oral agent . Patients register VADT .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>